Viewing Study NCT00915018


Ignite Creation Date: 2025-12-25 @ 4:58 AM
Ignite Modification Date: 2026-04-06 @ 5:20 AM
Study NCT ID: NCT00915018
Status: COMPLETED
Last Update Posted: 2018-08-22
First Post: 2009-06-04
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Study Evaluating Neratinib Plus Paclitaxel VS Trastuzumab Plus Paclitaxel In ErbB-2 Positive Advanced Breast Cancer
Sponsor: Puma Biotechnology, Inc.
Organization: